See more : Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sree Rayalaseema Hi-Strength Hypo Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- Chofu Seisakusho Co., Ltd. (5946.T) Income Statement Analysis – Financial Results
- Eagle Point Credit Company Inc. 6.6875% NT 28 (ECCX) Income Statement Analysis – Financial Results
- APM Human Services International Limited (APM.AX) Income Statement Analysis – Financial Results
- Alliance Global Group, Inc. (ALGGF) Income Statement Analysis – Financial Results
- Isonics Corporation (ISON) Income Statement Analysis – Financial Results
Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD.NS)
About Sree Rayalaseema Hi-Strength Hypo Limited
Sree Rayalaseema Hi-Strength Hypo Limited engages in the production and sale of chemicals in India. The company operates through two segments, Chemical Manufacturing and Power generation. It provides sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic acids; chloramine, purichlor, oleum, sodium dichloroisocyanurate, hydrogen gases; and aluminum sulphate, stable bleaching powder, sodium hydride, sodium methoxide powder, sodium methoxide solution, calcium hypochlorite, and water treatment chemicals. The company is involved in the generation and distribution of power through thermal, solar, and wind mills; and coal trading business. It also exports its products. Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in 2005 and is based in Kurnool, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.66B | 16.50B | 12.63B | 9.09B | 6.83B | 6.96B | 5.46B | 3.62B | 3.63B | 3.92B | 2.97B | 3.00B | 2.43B | 1.95B | 1.53B | 1.90B | 1.09B | 1.19B |
Cost of Revenue | 6.19B | 12.44B | 9.27B | 6.32B | 4.37B | 4.62B | 3.93B | 2.18B | 1.91B | 2.29B | 1.56B | 1.54B | 1.24B | 1.63B | 1.36B | 1.56B | 929.43M | 991.91M |
Gross Profit | 2.47B | 4.06B | 3.36B | 2.77B | 2.46B | 2.34B | 1.53B | 1.45B | 1.72B | 1.63B | 1.41B | 1.45B | 1.20B | 317.95M | 169.90M | 335.62M | 161.90M | 202.20M |
Gross Profit Ratio | 28.49% | 24.59% | 26.61% | 30.45% | 36.03% | 33.64% | 28.07% | 39.97% | 47.39% | 41.66% | 47.52% | 48.55% | 49.18% | 16.31% | 11.12% | 17.71% | 14.83% | 16.93% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.22M | 25.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 355.62M | 24.30M | 23.48M | 35.38M | 23.31M | 22.20M | 19.89M | 20.05M | 32.26M | 38.36M | 26.58M | 70.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 3.33M | 1.12B | 1.07B | 577.96M | 631.92M | 552.77M | 478.47M | 353.11M | 23.34M | 436.69M | 311.62M | 312.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 358.95M | 1.14B | 1.10B | 613.34M | 655.23M | 574.97M | 498.36M | 373.16M | 55.60M | 681.23M | 519.93M | 533.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 0.00 | 341.09M | 7.72M | 6.07M | 6.44M | 4.79M | 4.66M | 10.61M | 29.90M | 16.40M | 1.50M | 4.50M | 73.95M | 109.22M | 103.76M | 70.37M | 37.29M | 29.66M |
Operating Expenses | 358.95M | 2.47B | 2.06B | 1.97B | 1.94B | 1.76B | 1.26B | 1.20B | 1.40B | 1.35B | 1.19B | 1.22B | 806.31M | 88.57M | 37.22M | 79.26M | 68.45M | 87.30M |
Cost & Expenses | 6.55B | 14.92B | 11.33B | 8.29B | 6.31B | 6.38B | 5.19B | 3.37B | 3.31B | 3.64B | 2.74B | 2.76B | 2.04B | 1.72B | 1.40B | 1.64B | 997.87M | 1.08B |
Interest Income | 146.10M | 91.02M | 44.74M | 43.05M | 20.33M | 7.34M | 4.87M | 5.07M | 5.37M | 3.66M | 5.01M | 1.54M | 5.24M | 2.59M | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 39.85M | 20.32M | 19.56M | 43.24M | 86.90M | 74.17M | 70.00M | 63.88M | 93.53M | 88.35M | 92.41M | 78.94M | 74.79M | 110.15M | 109.74M | 69.45M | 37.43M | 30.45M |
Depreciation & Amortization | 104.23M | 193.47M | 192.27M | 506.08M | 502.74M | 450.70M | 187.96M | 103.51M | 97.17M | 225.53M | 149.11M | 131.99M | 119.80M | 109.68M | 94.34M | 54.60M | 42.34M | 33.96M |
EBITDA | 1.19B | 2.15B | 1.59B | 1.37B | 1.06B | 1.03B | 648.80M | 214.24M | 436.23M | 546.81M | 330.51M | 339.04M | 470.21M | 416.20M | 380.70M | 375.67M | 151.20M | 150.23M |
EBITDA Ratio | 13.76% | 12.84% | 12.13% | 14.85% | 15.28% | 13.77% | 8.19% | 13.63% | 12.62% | 12.89% | 12.82% | 12.42% | 20.96% | 22.37% | 26.37% | 20.75% | 13.99% | 12.59% |
Operating Income | 2.11B | 1.62B | 1.30B | 801.71M | 519.28M | 535.51M | 271.98M | 249.13M | 237.65M | 287.80M | 116.58M | 128.11M | 390.98M | 229.38M | 132.67M | 256.36M | 93.45M | 114.90M |
Operating Income Ratio | 24.34% | 9.79% | 10.30% | 8.82% | 7.61% | 7.69% | 4.98% | 6.88% | 6.54% | 7.33% | 3.93% | 4.27% | 16.06% | 11.77% | 8.68% | 13.53% | 8.56% | 9.62% |
Total Other Income/Expenses | -1.04B | -1.22B | -1.32B | -1.32B | -63.08M | -157.43M | -761.71M | -104.01M | -853.30M | -30.24M | -338.48M | -75.39M | -74.79M | -112.28M | 64.90M | -5.03M | -22.32M | -29.37M |
Income Before Tax | 1.07B | 1.90B | 1.37B | 808.43M | 454.44M | 422.06M | 370.14M | 145.13M | 254.74M | 257.57M | 116.58M | 128.11M | 275.20M | 193.95M | 197.58M | 251.32M | 71.13M | 85.53M |
Income Before Tax Ratio | 12.39% | 11.54% | 10.85% | 8.90% | 6.66% | 6.06% | 6.78% | 4.01% | 7.01% | 6.56% | 3.93% | 4.27% | 11.30% | 9.95% | 12.93% | 13.26% | 6.52% | 7.16% |
Income Tax Expense | 283.07M | 361.63M | 342.01M | 202.72M | 75.37M | 217.80M | 4.07M | -38.63M | 67.88M | 63.86M | 42.22M | 35.20M | 93.15M | -13.66M | 163.25M | 99.05M | 23.62M | 29.42M |
Net Income | 789.70M | 1.54B | 1.03B | 605.71M | 379.07M | 204.26M | 366.06M | 183.76M | 250.50M | 193.71M | 74.36M | 92.91M | 182.04M | 207.61M | 34.32M | 152.27M | 47.51M | 56.10M |
Net Income Ratio | 9.12% | 9.35% | 8.14% | 6.67% | 5.55% | 2.93% | 6.70% | 5.07% | 6.89% | 4.94% | 2.51% | 3.10% | 7.48% | 10.65% | 2.25% | 8.04% | 4.35% | 4.70% |
EPS | 46.01 | 89.87 | 59.88 | 35.29 | 22.08 | 11.90 | 22.45 | 11.86 | 17.02 | 13.16 | 5.05 | 6.53 | 13.02 | 19.49 | 3.28 | 14.95 | 4.67 | 5.51 |
EPS Diluted | 46.01 | 89.87 | 59.88 | 35.29 | 22.08 | 11.90 | 21.33 | 10.71 | 17.02 | 13.16 | 5.05 | 6.53 | 13.02 | 19.49 | 3.28 | 14.95 | 4.67 | 5.51 |
Weighted Avg Shares Out | 17.17M | 17.16M | 17.17M | 17.17M | 17.17M | 17.17M | 16.31M | 15.49M | 14.72M | 14.72M | 14.72M | 14.22M | 13.98M | 10.95M | 10.45M | 10.18M | 10.18M | 10.18M |
Weighted Avg Shares Out (Dil) | 17.17M | 17.16M | 17.17M | 17.17M | 17.17M | 17.17M | 17.17M | 17.17M | 14.72M | 14.72M | 14.72M | 14.22M | 13.98M | 10.95M | 10.45M | 10.18M | 10.18M | 10.18M |
Source: https://incomestatements.info
Category: Stock Reports